Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading under the ticker PWUP, is a biopharma-focused special purpose acquisition company currently in the registration amendment stage, having filed an S-1/A with the SEC on April 10, 2026, under accession number 0001493152-26-016123. The S-1/A filing signals an active update to the company's registration statement, a step that commonly precedes or accompanies a de-SPAC transaction or post-merger share registration in the life sciences and biopharma sector. As a healthcare-adjacent SPAC vehicle, Aspire Biopharma Holdings targets the biopharmaceutical industry, a space that has drawn sustained SPAC interest. Sign up for full data on SpacDesk to access complete filing history, deal timelines, and structured analytics on PWUP and hundreds of other active SPAC vehicles.